1. Home /
  2. Investing /
  3. Cannabis

Cannabis  

Canaccord Isn't Overly Worried About 2 Pot Stocks Whose CEOs Recently Left

The firm rates MJardin as a 'Hold' and Tilt Holdings as a 'Speculative Buy.'

Canopy Growth Is Ready for an Upside Move: When to Go Long

Let's visit with the charts and indicators to see how things are shaping up today.

Checking Back With Tesla and Alphabet, and Checking Out 2 Other Names

Besides revisiting the first two companies, we also look at trade setups for Canopy Growth and Nike.

Cannabis Firm Cresco Labs Skips the Flash, Keeps It Real

With over 56 brands, CRLBF has something for everyone and that is the secret sauce of this unassuming company.

Hemp Is No Ordinary Crop and Market

The market for hemp-derived products is exploding and financial instruments that are going to be created to work within the market will grow, too.

Taking a Hit on Cannabis Stock CannTrust Holdings

I believe the best move here is to cut the position in half and take a loss.

Everything Cannabis Investors Need to Know About This Year's 420 'Holiday'

Sales for Pot Holiday 420 will get rolling early this year. Any cannabis investor should pay attention.

Canopy Growth Now Has to be Considered the Leader in the Canadian Cannabis Space

CGC has the best chance to transition to broader success should the U.S. ever go the route of legalization beyond the state level.

The SEC Should Investigate Citron, Not Village Farms

For aggressive investors seeking to broaden their exposure in the cannabis and CBD space, I view VFF as an opportunity.

I Own Alphria Stock and the Big Q3 Loss Was Not a Surprise

The company has spent a lot of time and money trying to meet the supply needs of the recreational cannabis market.

2 Huge Earnings Reports I'm Watching This Week

A pair of earnings report this week will shed light on the future direction of two fast-growing companies in very different fields.

9 Speculative Plays for Investors Wanting Cannabis Exposure

Five top marijuana stocks and four CBD plays in this speculative space.

Here's How to Trade Constellation Brands Stock

Oh, by the way, Constellation, for those who've forgotten, holds a 38% stake in Canopy Growth.

Constellation Brands Stock Can Still Run Despite Downgrade

There is certainly too much to ignore about STZ for the majority of analysts.

DionyMed Split From Eaze to Affect Revenue

The cannabis company said it was going to invest in its own delivery service called "Chill."

Shift to CBD From Cigarettes Isn't Enough to Sustain Walgreens Stock

In fact, the de-emphasizing of cigarettes was blamed for declining same store sales.

This CBD Options Play With Walgreens Is Smoking

Is Walgreens now a cannabis value play?

If Cannabis Firm Vireo Gets a Green Light, Bargain Hunters May Want to Invest

This legal-marijuana company is flying under the radar after a scandal involving two ex-employees.

Cronos Group's High Times May Be About to Wear Off

Charts of this type are frequently found to be topping patterns.

Cronos Group Certainly Qualifies for Mainstream Consideration

Revenue is where it's at for cannabis in 2019.

2 Big Earnings Reports I'll Be Watching This Week

A huge week is coming up for these well-known stocks.

7 Indirect Stock Plays on the Cannabis Sector

Investors can gain exposure to the high-flying cannabis industry without taking on undue risks.

Plus Cannabis Gummies Get a 'Speculative Buy' Rating With a Delicious Outlook

If Plus cannabis gummies are a big hit, just think how consumers will respond to hemp-derived CBD gummies.

Cause for Caution? Top Executives Selling Tilray Stock

It might not be time to panic yet about Tilray, but there's likely a problem ahead.

With Tilray, You Won't Win Any Valuation Arguments

Short interest is back in the low single digits while Tilray still enjoys one of the smallest floats for a cannabis company.

Another Hemp Play to Consider: Charlotte's Web Holdings

Investors looking for another hemp play might consider Charlotte's Web Holdings, which deals in a range of CBD wellness products.

Tilray Touts Global Ambition as Erosion of Canadian Market Expected

A key aspect of the international expansion is the company's recent acquisition of hemp-food producer Manitoba Harvest in February.

Tilray Is Not My Favorite Canadian Cannabis Stock

Apparently, this game is all about growth right now. It certainly is not about margins.

Kass: Tilray Is Promising but I Prefer This Other Stock in the Pot Space

Tilray will not be cash flow positive for another 2-3 years - that's not quick enough progress for me given its $7 billion dollar capitalization.

Tilray Has Rebased and Looks Poised to Rally Again - Consider Buying Strength

Let's check out the charts and indicators for this so-called pot play.